Positron emission tomography imaging of neuroinflammation

Journal of Child Neurology

Volumn 24, Issue 9, 2009, Pages 1190-1199

  Kannan, Sujatha ^a   Balakrishnan, Bindu ^a   Muzik, Otto ^a   Romero, Roberto ^a,b   Chugani, Diane ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Neuroinflammation; PET

Indexed keywords

BENZODIAZEPINE RECEPTOR; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE C 11; PERIPHERAL BENZODIAZEPINE RECEPTOR; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; BRAIN INJURY; CELL ACTIVATION; CELL FUNCTION; CEREBRAL PALSY; CHORIOAMNIONITIS; DEGENERATIVE DISEASE; ENCEPHALITIS; ENCEPHALOMALACIA; HUMAN; INFLAMMATORY INFILTRATE; MICROGLIA; NEWBORN PERIOD; NONHUMAN; PERINATAL PERIOD; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN FUNCTION;

ANIMALS; ANTINEOPLASTIC AGENTS; BRAIN MAPPING; CARBON ISOTOPES; DISEASE MODELS, ANIMAL; ENCEPHALITIS; HUMANS; ISOQUINOLINES; MICROGLIA; MODELS, BIOLOGICAL; POSITRON-EMISSION TOMOGRAPHY; RABBITS; RECEPTORS, GABA-A;

EID: 70349298854     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/0883073809338063     Document Type: Article

References (96)

1. Wu YW, Escobar GJ, Grether JK, Croen LA, Greene JD, Newman TB Chorioamnionitis and cerebral palsy in term and near-term infants. JAMA. 2003; 290(20): 2677-2684.
2. Bell MJ, Hallenbeck JM Effects of intrauterine inflammation on developing rat brain. J Neurosci Res. 2002; 70(4): 570-579.
3. Cai Z., Pan ZL, Pang Y., Evans OB, Rhodes PG Cytokine induction in fetal rat brains and brain injury in neonatal rats after maternal lipopolysaccharide administration. Pediatr Res. 2000; 47(1): 64-72.
4. Saadani-Makki F., Kannan S., Lu X., et al. Intrauterine administration of endotoxin leads to motor deficits in a rabbit model: A link between prenatal infection and cerebral palsy. Am J Obstet Gynecol. 2008; 199(6): 651-657.
5. Espey MG, Chernyshev ON, Reinhard JF Jr, Namboodiri MA, Colton CA Activated human microglia produce the excitotoxin quinolinic acid. Neuroreport. 1997; 8(2): 431-434.
6. Li J., Baud O., Vartanian T., Volpe JJ, Rosenberg PA Peroxynitrite generated by inducible nitric oxide synthase and NADPH oxidase mediates microglial toxicity to oligodendrocytes. Proc Natl Acad Sci U S A. 2005; 102(28): 9936-9941.
7. Block ML, Zecca L., Hong JS Microglia-mediated neurotoxicity: Uncovering the molecular mechanisms. Nat Rev Neurosci. 2007; 8(1): 57-69.
8. Lawson LJ, Perry VH, Dri P., Gordon S. Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience. 1990; 39(1): 151-170.
9. Vilhardt F. Microglia: Phagocyte and glia cell. Int J Biochem Cell Biol. 2005; 37(1): 17-21.
10. Nimmerjahn A., Kirchhoff F., Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science. 2005; 308(5726): 1314-1318.
11. Billiards SS, Haynes RL, Folkerth RD, et al. Development of microglia in the cerebral white matter of the human fetus and infant. J Comp Neurol. 2006; 497(2): 199-208.
12. Dheen ST, Kaur C., Ling EA Microglial activation and its implications in the brain diseases. Curr Med Chem. 2007; 14(11): 1189-1197.
13. Pekny M., Nilsson M. Astrocyte activation and reactive gliosis. Glia. 2005; 50(4): 427-434.
14. Lossinsky AS, Shivers RR Structural pathways for macromolecular and cellular transport across the blood-brain barrier during inflammatory conditions. Review. Histol Histopathol. 2004; 19(2): 535-564.
15. O'Callaghan JP, Sriram K., Miller DB Defining "neuroinflammation.". Ann N Y Acad Sci. 2008; 1139: 318-330.
16. Gray E., Thomas TL, Betmouni S., Scolding N., Love S. Elevated activity and microglial expression of myeloperoxidase in demyelinated cerebral cortex in multiple sclerosis. Brain Pathol. 2008; 18(1): 86-95.
17. Mosley RL, Benner EJ, Kadiu I., et al. Neuroinflammation, oxidative stress and the pathogenesis of Parkinson's disease. Clin Neurosci Res. 2006; 6(5): 261-281.
18. Rojo LE, Fernandez JA, Maccioni AA, Jimenez JM, Maccioni RB Neuroinflammation: Implications for the pathogenesis and molecular diagnosis of Alzheimer's disease. Arch Med Res. 2008; 39(1): 1-16.
19. Crocker SJ, Whitmire JK, Frausto RF, et al. Persistent macrophage/ microglial activation and myelin disruption after experimental autoimmune encephalomyelitis in tissue inhibitor of metalloproteinase-1-deficient mice. Am J Pathol. 2006; 169(6): 2104-2116.
20. Bolmont T., Haiss F., Eicke D., et al. Dynamics of the microglial/ amyloid interaction indicate a role in plaque maintenance. J Neurosci. 2008; 28(16): 4283-4292.
21. Hickman SE, Allison EK, El Khoury J. Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice. Neuroscience. 2008; 28(33): 8354-8360.
22. Fahn S., Przedborski S. Parkinsonism. In Merritts neurology. In: Rowland LP, ed. New York, NY: Lippincott; 2000: 679-693.
23. Jaseja H. Cerebral palsy: Interictal epileptiform discharges and cognitive impairment. Clin Neurol Neurosurg. 2007; 109(7): 549-552.
24. Francalanci P., Eymard-Pierre E., Dionisi-Vici C., et al. Fatal infantile leukodystrophy: A severe variant of CACH/VWM syndrome, allelic to chromosome 3q27. Neurology. 2001; 57(2): 265-270.
25. Vargas DL, Nascimbene C., Krishnan C., Zimmerman AW, Pardo CA Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol. 2005; 57(1): 67-81.
26. Banati RB, Goerres GW, Myers R., et al. [11C](R)-PK11195 positron emission tomography imaging of activated microglia in vivo in Rasmussen's encephalitis. Neurology. 1999; 53(9): 2199-2203.
27. Kumar A., Chugani HT, Luat A., Asano E., Sood S. Epilepsy surgery in a case of encephalitis: Use of 11C-PK11195 positron emission tomography. Pediatr Neurol. 2008; 38(6): 439-442.
28. Taniwaki Y., Kato M., Araki T., Kobayashi T. Microglial activation by epileptic activities through the propagation pathway of kainic acid-induced hippocampal seizures in the rat. Neurosci Lett. 1996; 217(1): 29-32.
29. Borda JT, Alvarez X., Mohan M., et al. Clinical and immunopathologic alterations in rhesus macaques affected with globoid cell leukodystrophy. Am J Pathol. 2008; 172(1): 98-111.
30. McGuinness MC, Powers JM, Bias WB, et al. Human leukocyte antigens and cytokine expression in cerebral inflammatory demyelinative lesions of X-linked adrenoleukodystrophy and multiple sclerosis. J Neuroimmunol. 1997; 75(1-2): 174-182.
31. Dammann O., Leviton A. Infection remote from the brain, neonatal white matter damage, and cerebral palsy in the preterm infant. Semin Pediatr Neurol. 1998; 5(3): 190-201.
32. O'Shea TM, Kothadia JM, Roberts DD, Dillard RG Perinatal events and the risk of intraparenchymal echodensity in very-low-birthweight neonates. Paediatr Perinat Epidemiol. 1998; 12(4): 408-421.
33. Bejar RF, Vaucher YE, Benirschke K., Berry CC Postnatal white matter necrosis in preterm infants. J Perinatol. 1992; 12(1): 3-8.
34. Haynes RL, Folkerth RD, Keefe RJ, et al. Nitrosative and oxidative injury to premyelinating oligodendrocytes in periventricular leukomalacia. J Neuropathol Exp Neurol. 2003; 62(5): 441-450.
35. Volpe JJ Neurobiology of periventricular leukomalacia in the premature infant. Pediatr Res. 2001; 50(5): 553-562.
36. Volpe JJ Cerebral white matter injury of the premature infant-more common than you think. Pediatrics. 2003; 112(1 pt 1): 176-180.
37. Martinez E., Figueroa R., Garry D., et al. Elevated amniotic fluid interleukin-6 as a predictor of neonatal periventricular leukomalacia and intraventricular hemorrhage. J Matern Fetal Investig. 1998; 8(3): 101-107.
38. Yoon BH, Romero R., Park JS, et al. Fetal exposure to an intra-amniotic inflammation and the development of cerebral palsy at the age of three years. Am J Obstet Gynecol. 2000; 182(3): 675-681.
39. Lonergan M., Aponso D., Marvin KW, et al. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), TRAIL receptors, and the soluble receptor osteoprotegerin in human gestational membranes and amniotic fluid during pregnancy and labor at term and preterm. J Clin Endocrinol Metab. 2003; 88(8): 3835-3844.
40. Nelson KB, Dambrosia JM, Grether JK, Phillips TM Neonatal cytokines and coagulation factors in children with cerebral palsy. Ann Neurol. 1998; 44(4): 665-675.
41. du Plessis AJ, Volpe JJ Perinatal brain injury in the preterm and term newborn. Curr Opin Neurol. 2002; 15(2): 151-157.
42. Hailer NP, Vogt C., Korf HW, Dehghani F. Interleukin-1beta exacerbates and interleukin-1 receptor antagonist attenuates neuronal injury and microglial activation after excitotoxic damage in organotypic hippocampal slice cultures. Eur J Neurosci. 2005; 21(9): 2347-2360.
43. Lehnardt S., Lachance C., Patrizi S., et al. The toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS. J Neurosci. 2002; 22(7): 2478-2486.
44. Dommergues MA, Plaisant F., Verney C., Gressens P. Early microglial activation following neonatal excitotoxic brain damage in mice: A potential target for neuroprotection. Neuroscience. 2003; 121(3): 619-628.
45. Hagberg H., Peebles D., Mallard C. Models of white matter injury: comparison of infectious, hypoxic-ischemic, and excitotoxic insults. Ment Retard Dev Disabil Res Rev. 2002; 8(1): 30-38.
46. Gurley C., Nichols J., Liu S., Phulwani NK, Esen N., Kielian T. Microglia and astrocyte activation by toll-like receptor ligands: modulation by PPAR-gamma agonists. PPAR Res. 2008; 2008: 453120.
47. Fern R., Moller T. Rapid ischemic cell death in immature oligodendrocytes: A fatal glutamate release feedback loop. J Neurosci. 2000; 20(1): 34-42.
48. Salter MG, Fern R. NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury. Nature. 2005; 438(7071): 1167-1171.
49. Garnier M., Boujrad N., Ogwuegbu SO, Hudson JR Jr, Papadopoulos V. The polypeptide diazepam-binding inhibitor and a higher affinity mitochondrial peripheral-type benzodiazepine receptor sustain constitutive steroidogenesis in the R2C Leydig tumor cell line. J Biol Chem. 1994; 269(35): 22105-22112.
50. Braestrup C., Squires RF Specific benzodiazepine receptors in rat brain characterized by high-affinity (3H)diazepam binding. Proc Natl Acad Sci U S A. 1977; 74(9): 3805-3809.
51. Gavish M., Bachman I., Shoukrun R., et al. Enigma of the peripheral benzodiazepine receptor. Pharmacol Rev. 1999; 51(4): 629-650.
52. Papadopoulos V., Baraldi M., Guilarte TR, et al. Translocator protein (18kDa): New nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol Sci. 2006; 27(8): 402-409.
53. Papadopoulos V., Widmaier EP, Amri H., et al. In vivo studies on the role of the peripheral benzodiazepine receptor (PBR) in steroidogenesis. Endocr Res. 1998; 24(3-4): 479-487.
54. Casellas P., Galiegue S., Basile AS Peripheral benzodiazepine receptors and mitochondrial function. Neurochem Int. 2002; 40(6): 475-486.
55. Banati RB Visualising microglial activation in vivo. Glia. 2002; 40(2): 206-217.
56. Gerhard A., Banati RB, Goerres GB, et al. [11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy. Neurology. 2003; 61(5): 686-689.
57. McEnery MW, Snowman AM, Trifiletti RR, Snyder SH Isolation of the mitochondrial benzodiazepine receptor: Association with the voltage-dependent anion channel and the adenine nucleotide carrier. Proc Natl Acad Sci U S A. 1992; 89(8): 3170-3174.
58. Hirsch JD, Beyer CF, Malkowitz L., Beer B., Blume AJ Mitochondrial benzodiazepine receptors mediate inhibition of mitochondrial respiratory control. Mol Pharmacol. 1989; 35(1): 157-163.
59. Wang JK, Morgan JI, Spector S. Benzodiazepines that bind at peripheral sites inhibit cell proliferation. Proc Natl Acad Sci U S A. 1984; 81(3): 753-756.
60. Lenfant M., Haumont J., Zavala F. In vivo immunomodulating activity of PK 1195, a structurally unrelated ligand for "peripheral" benzodiazepine binding sites-I. Potentiation in mice of the humoral response to sheep red blood cells. Int J Immunopharmacol. 1986; 8(7): 825-828.
61. Ruff MR, Pert CB, Weber RJ, Wahl LM, Wahl SM, Paul SM Benzodiazepine receptor-mediated chemotaxis of human monocytes. Science. 1985; 229(4719): 1281-1283.
62. Banati RB, Newcombe J., Gunn RN, et al. The peripheral benzodiazepine binding site in the brain in multiple sclerosis: Quantitative in vivo imaging of microglia as a measure of disease activity. Brain. 2000; 123(pt 11): 2321-2337.
63. Chen MK, Guilarte TR Imaging the peripheral benzodiazepine receptor response in central nervous system demyelination and remyelination. Toxicol Sci. 2006; 91(2): 532-539.
64. Chen MK, Baidoo K., Verina T., Guilarte TR Peripheral benzodiazepine receptor imaging in CNS demyelination: Functional implications of anatomical and cellular localization. Brain. 2004; 127(pt 6): 1379-1392.
65. Kuhlmann AC, Guilarte TR Cellular and subcellular localization of peripheral benzodiazepine receptors after trimethyltin neurotoxicity. J Neurochem. 2000; 74(4): 1694-1704.
66. Chen MK, Guilarte TR Translocator protein 18 kDa (TSPO): Molecular sensor of brain injury and repair. Pharmacol Ther. 2008; 118(1): 1-17.
67. James ML, Selleri S., Kassiou M. Development of ligands for the peripheral benzodiazepine receptor. Curr Med Chem. 2006; 13(17): 1991-2001.
68. Papadopoulos V., Amri H., Boujrad N., et al. Peripheral benzodiazepine receptor in cholesterol transport and steroidogenesis. Steroids. 1997; 62(1): 21-28.
69. Gerhard A., Trender-Gerhard I., Turkheimer F., Quinn NP, Bhatia KP, Brooks DJ In vivo imaging of microglial activation with [11C](R)-PK11195 PET in progressive supranuclear palsy. Mov Disord. 2006; 21(1): 89-93.
70. Black KL, Ikezaki K., Santori E., Becker DP, Vinters HV Specific high-affinity binding of peripheral benzodiazepine receptor ligands to brain tumors in rat and man. Cancer. 1990; 65(1): 93-97.
71. Okello A., Edison P., Archer HA, et al. Microglial activation and amyloid deposition in mild cognitive impairment: A PET study. Neurology. 2009; 72(1): 56-62.
72. Edison P., Archer HA, Gerhard A., et al. Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study. Neurobiol Dis. 2008; 32(3): 412-419.
73. Cagnin A., Brooks DJ, Kennedy AM, et al. In-vivo measurement of activated microglia in dementia. Lancet. 2001; 358(9280): 461-467.
74. van Berckel BN, Bossong MG, Boellaard R., et al. Microglia activation in recent-onset schizophrenia: A quantitative (R)[11C]PK11195 positron emission tomography study. Biol Psychiatry. 2008; 64(9): 820-822.
75. Vas A., Shchukin Y., Karrenbauer VD, et al. Functional neuroimaging in multiple sclerosis with radiolabelled glia markers: Preliminary comparative PET studies with [11C]vinpocetine and [11C]PK11195 in patients. J Neurol Sci. 2008; 264(1-2): 9-17.
76. Tai YF, Pavese N., Gerhard A., et al. Microglial activation in presymptomatic Huntington's disease gene carriers. Brain. 2007; 130(pt 7): 1759-1766.
77. Pavese N., Gerhard A., Tai YF, et al. Microglial activation correlates with severity in Huntington disease: A clinical and PET study. Neurology. 2006; 66(11): 1638-1643.
78. Messmer K., Reynolds GP Increased peripheral benzodiazepine binding sites in the brain of patients with Huntington's disease. Neurosci Lett. 1998; 241(1): 53-56.
79. Gerhard A., Pavese N., Hotton G., et al. In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease. Neurobiol Dis. 2006; 21(2): 404-412.
80. Ouchi Y., Yoshikawa E., Sekine Y., et al. Microglial activation and dopamine terminal loss in early Parkinson's disease. Ann Neurol. 2005; 57(2): 168-175.
81. Henkel K., Karitzky J., Schmid M., et al. Imaging of activated microglia with PET and [11C]PK 11195 in corticobasal degeneration. Mov Disord. 2004; 19(7): 817-821.
82. Gerhard A., Watts J., Trender-Gerhard I., et al. In vivo imaging of microglial activation with [11C](R)-PK11195 PET in corticobasal degeneration. Mov Disord. 2004; 19(10): 1221-1226.
83. Turner MR, Cagnin A., Turkheimer FE, et al. Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: An [11C](R)-PK11195 positron emission tomography study. Neurobiol Dis. 2004; 15(3): 601-609.
84. Gerhard A., Neumaier B., Elitok E., et al. In vivo imaging of activated microglia using [11C]PK11195 and positron emission tomography in patients after ischemic stroke. Neuroreport. 2000; 11(13): 2957-2960.
85. Ramsay SC, Weiller C., Myers R., et al. Monitoring by PET of macrophage accumulation in brain after ischaemic stroke. Lancet. 1992; 339(8800): 1054-1055.
86. Pappata S., Levasseur M., Gunn RN, et al. Thalamic microglial activation in ischemic stroke detected in vivo by PET and [11C]PK1195. Neurology. 2000; 55(7): 1052-1054.
87. Shah F., Hume SP, Pike VW, Ashworth S., McDermott J. Synthesis of the enantiomers of [N-methyl-11C]PK 11195 and comparison of their behaviours as radioligands for PK binding sites in rats. Nucl Med Biol. 1994; 21(4): 573-581.
88. Kannan S., Saadani-Makki F., Muzik O., et al. Microglial activation in perinatal rabbit brain induced by intrauterine inflammation: Detection with 11C-(R)-PK11195 and small-animal PET. J Nucl Med. 2007; 48(6): 946-954.
89. Myers R., Manjil LG, Cullen BM, Price GW, Frackowiak RS, Cremer JE Macrophage and astrocyte populations in relation to [3H]PK 11195 binding in rat cerebral cortex following a local ischaemic lesion. J Cereb Blood Flow Metab. 1991; 11(2): 314-322.
90. Venneti S., Wagner AK, Wang G., et al. The high affinity peripheral benzodiazepine receptor ligand DAA1106 binds specifically to microglia in a rat model of traumatic brain injury: Implications for PET imaging. Exp Neurol. 2007; 207(1): 118-127.
91. Dumont F., De VF, Versijpt J., et al. In vivo evaluation in mice and metabolism in blood of human volunteers of [123I]iodo-PK11195: A possible single-photon emission tomography tracer for visualization of inflammation. Eur J Nucl Med. 1999; 26(3): 194-200.
92. Lammertsma AA, Hume SP Simplified reference tissue model for PET receptor studies. Neuroimage. 1996; 4(3 pt 1): 153-158.
93. Boutin H., Chauveau F., Thominiaux C., et al. 11C-DPA-713: A novel peripheral benzodiazepine receptor PET ligand for in vivo imaging of neuroinflammation. J Nucl Med. 2007; 48(4): 573-581.
94. Monier A., Adle-Biassette H., Delezoide AL, Evrard P., Gressens P., Verney C. Entry and distribution of microglial cells in human embryonic and fetal cerebral cortex. J Neuropathol Exp Neurol. 2007; 66(5): 372-382.
95. Chugani DC, Kedersha NL, Rome LH Vault immunofluoresence in the brain: new insights regarding the origin of microglia. J Neurosci. 1991; 11(1): 256-268.
96. Brenner DJ, Hall EJ Computed tomography-an increasing source of radiation exposure. N Engl J Med. 2007; 357(22): 2277-2284.